Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil during delayed extubation after craniotomy
ChiCTR-PRC-13003879Phase 4Completed
- Sponsor
- Department of Critical Care Medicine, Beijing Tiantan Hospital Affiliated to Capital Medical University
- Start
- Jan 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remifentanil in postoperative pain (2 arms), sponsored by Department of Critical Care Medicine, Beijing Tiantan Hospital Affiliated to Capital Medical University. Primary endpoint: Percentage of patients with severe pain during extubation. Started Jan 2014; status: completed.
02
Drugs
remifentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR-PRC-13003879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PRC-13003879.